Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -55.43% away from its 52-week high, while its distance from the 52-week low is 41.15%. The stock’s price range over this period has fluctuated between $4.97 and $15.74. The company, operating within the financial sector, had a trading volume of approximately 0.9 million for the day, which was noticeably lower than the average daily share volume of 5.78 million over the last 3 months.
The market performance of Recursion Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $15.74 on 02/27/24, while the lowest value for the same duration was $4.97 on 11/01/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -19.92% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.02B.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.89, with a change in price of -1.80. Similarly, Recursion Pharmaceuticals Inc recorded 5,417,089 in trading volume during the last 100 days, posting a change of -20.53%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.13.
RXRX Stock Stochastic Average
Today, Recursion Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 38.60%, indicating a decline from the raw stochastic average of the last 20 days, which was 57.14%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 46.01% and 42.21% respectively.
RXRX Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -28.85%. However, over the past six months, we’ve seen a stronger performance of -32.03%. The price of RXRX leaped by -11.09% over the last 30 days. And in the last five days, it has surged by 1.52%.
